Publikace
- Cyclin-dependent kinase inhibitors AZD5438 and R547 show potential for enhancing efficacy of daunorubicin-based anticancer therapy: Interaction with carbonyl-reducing enzymes and ABC transporters2019 | Farmaceutická fakulta v Hradci Králové
- Determination of Hypericin in Hypericum perforatum (St. John's Wort) Using Classical C18 and Pentafluorophenyl Stationary Phases: Contribution of Pi-Pi Interactions to High-Performance Liquid Chromatography (HPLC)2019 | Farmaceutická fakulta v Hradci Králové
- Buparlisib is a novel inhibitor of daunorubicin reduction mediated by aldo-keto reductase 1C32019 | Farmaceutická fakulta v Hradci Králové
- Phenolic N-monosubstituted carbamates: Antitubercular and toxicity evaluation of multi-targeting compounds2019 | Farmaceutická fakulta v Hradci Králové
- Aldo-keto reductase 1C3 (AKR1C3): a missing piece of the puzzle in the dinaciclib interaction profile2018 | Farmaceutická fakulta v Hradci Králové
- Roscovitine and purvalanol A effectively reverse anthracycline resistance mediated by the activity of aldo-keto reductase 1C3 (AKR1C3): A promising therapeutic target for cancer treatment2018 | Farmaceutická fakulta v Hradci Králové
- Design, Synthesis, and Biological Evaluation of Isothiosemicarbazones with Antimycobacterial Activity2017 | Farmaceutická fakulta v Hradci Králové
- Flavones Inhibit the Activity of AKR1B10, a Promising Therapeutic Target for Cancer Treatment2015 | Farmaceutická fakulta v Hradci Králové
- Salicylanilide pyrazinoates inhibit in vitro multidrug-resistant Mycobacterium tuberculosis strains, atypical mycobacteria and isocitrate lyase2014 | Farmaceutická fakulta v Hradci Králové
- Synthesis and biological activity of new salicylanilide N,N-disubstituted carbamates and thiocarbamates2014 | Farmaceutická fakulta v Hradci Králové
Loading network view...